Group a streptococcal infections and acute rheumatic fever

New England Journal of Medicine

Volumn 325, Issue 11, 1991, Pages 783-793

  Bisno, Alan L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; ETIOLOGY; HUMAN; INCIDENCE; PHARYNGITIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC FEVER; STREPTOCOCCUS GROUP A; TOXIC SHOCK SYNDROME; UNITED STATES; ACUTE DISEASE; MICROBIOLOGY; RECURRENT DISEASE; SEPTIC SHOCK; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ACUTE DISEASE; HUMAN; INCIDENCE; PHARYNGITIS; RECURRENCE; RHEUMATIC FEVER; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; UNITED STATES;

EID: 0026423120     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199109123251106     Document Type: Review

References (151)

1. Peter G., Smith A.L. Group A streptococcal infections of the skin and pharynx. N Engl J Med 1977; 297:311-7, 365-70.
2. Lancefield R.C. Current knowledge of type-specific M antigens of group A streptococci. J Immunol 1962; 89:307-313
3. Bisno A.L. Management of streptococcal infections and prevention of rheumatic fever: the changing scene. In: Sande MA, Hudson LD, Root RK, eds. Respiratory infections. Vol. 5 of Contemporary issues in infectious diseases. New York: Churchill Livingstone, 1986: 217-34.
4. Beachey E.H., Stollerman G.H., Chiang E.Y., Chiang T.M., Seyer J.M., Kang A.H. Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen. J Exp Med 1977; 145:1469-1483
5. Beachey E.H., Seyer J.M., Dale J.B., Hasty D.L. Repeating covalent structure and protective immunogenicity of native and synthetic polypeptide fragments of type 24 streptococcal M protein: mapping of protective and non-protective epitopes with monoclonal antibodies. J Biol Chem 1983; 258:13250-7.
6. Phillips G.N. Jr., Flicker P.F., Cohen C., Manjula B.N., Fischetti V.A. Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface. Proc Natl Acad Sci U S A 1981; 78:4689-4693
7. Fischetti V.A., Jones K.F., Hollingshead S.K., Scott J.R. Structure, function, and genetics of streptococcal M protein. Rev Infect Dis 1988; 10:Suppl 2:S356-S359.
8. Bisno A.L. Alternate complement pathway activation by group A streptococci: role of M-protein. Infect Immun 1979; 26:1172-1176
9. Peterson P.K., Schmeling D., Cleary P.P., Wilkinson B.J., Kim Y., Quie P.G. Inhibition of alternative complement pathway opsonization by group A streptococcal M protein. J Infect Dis 1979; 139:575-585
10. Lancefield R.C. Persistence of type-specific antibodies in man following infection with Group A streptococci. J Exp Med 1959; 110:271-292
11. Quinn R.W., Vander Zwaag R., Lowry P.N. Acquisition of group A streptococcal M protein antibodies. Pediatr Infect Dis J 1985; 4:374-378
12. Guirguis N., Fraser D.W., Facklam R.R., El Kholy A., Wannamaker L.W. Type-specific immunity and pharyngeal acquisition of group A streptococcus. Am J Epidemiol 1982; 116:933-939
13. Wannamaker L.W. The epidemiology of streptococcal infection. In: McCarty M, ed. Streptococcal infections. New York: Columbia University Press, 1953: 157-75.
14. Denny F.W., Perry W.D., Wannamaker L.W. Type-specific streptococcal antibody. J Clin Invest 1957; 36:1092-1100
15. Bessen D., Fischetti V.A. Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A. J Exp Med 1988; 167:1945-1950
16. Beachey E.H., Ofek I. Epithelial cell binding of group A streptococci by lipoteichoic acid on fimbriae denuded of M protein. J Exp Med 1976; 143:759-771
17. Beachey E.H., Simpson W.A., Ofek I., Hasty D.L., Dale J.B., Whitnack E. Attachment of Streptococcus pyogenes to mammalian cells. Rev Infect Dis 1983; 5:Suppl 4:S670-S677.
18. Simpson W.A., Courtney H.S., Ofek I. Interactions of fibronectin with streptococci: the role of fibronectin as a receptor for Streptococcus pyogenes. Rev Infect Dis 1987; 9:Suppl 4:S351-S359.
19. Kass E.H., Seastone C.V. The role of the mucoid polysaccharide (hyaluronic acid) in the virulence of group A hemolytic streptococci. J Exp Med 1944; 79:319-330
20. Stollerman G.H. Rheumatogenic group A streptococci and the return of rheumatic fever. Adv Intern Med 1990; 35:1-25.
21. Kim Y.B., Watson D.W. Streptococcal exotoxins: biological and pathological properties. In: Wannamaker LW, Matsen JM, eds. Streptococci and streptococcal diseases: recognition, understanding, and management. New York: Academic Press, 1972: 33-50.
22. Schlievert P.M., Bettin K.M., Watson D.W. Reinterpretation of the Dick test: role of group A streptococcal pyrogenic exotoxin. Infect Immun 1979; 26:467-472
23. Breese B.B. A simple scorecard for the tentative diagnosis of streptococcal pharyngitis. Am J Dis Child 1977; 131:514-517
24. Tompkins R.K., Burnes D.C., Cable W.E. An analysis of the cost-effectiveness of pharyngitis management and acute rheumatic fever prevention. Ann Intern Med 1977; 86:481-492
25. Cebul R.D., Poses R.M. The comparative cost-effectiveness of statistical decision rules and experienced physicians in pharyngitis management. JAMA 1986; 256:3353-3357
26. Kellogg J.A. Suitability of throat culture procedures for detection of group A streptococci and as reference standards for evaluation of streptococcal antigen detection kits. J Clin Microbiol 1990; 28:165-169
27. Gerber M.A. Comparison of throat cultures and rapid strep tests for diagnosis of streptococcal pharyngitis. Pediatr Infect Dis J 1989; 8:820-824
28. Holmberg S.D., Faich G.A. Streptococcal pharyngitis and acute rheumatic fever in Rhode Island. JAMA 1983; 250:2307-2312
29. Cochi S.L., Fraser D.W., Hightower A.W., Facklam R.R., Broome C.V. Diagnosis and treatment of streptococcal pharyngitis: survey of U.S. medical practitioners. In: Shulman ST, ed. Pharyngitis: management in an era of declining rheumatic fever. New York: Praeger Scientific, 1984: 73-94.
30. Randolph M.F., Gerber M.A., DeMeo K.K., Wright L. Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. J Pediatr 1985; 106:870-875
31. Krober M.S., Bass J.W., Michels G.N. Streptococcal pharyngitis: placebo-controlled double-blind evaluation of clinical response to penicillin therapy. JAMA 1985; 253:1271-1274
32. Nelson J.D. The effect of penicillin therapy on the symptoms and signs of streptococcal pharyngitis. Pediatr Infect Dis 1984; 3:10-13
33. Kellogg J.A., Manzella J.P. Detection of group A streptococci in the laboratory or physician#x0027;s office. JAMA 1986; 255:2638-2642
34. Gastanaduy A.S., Kaplan E.L., Huwe B.B., McKay C., Wannamaker L.W. Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis. Lancet 1980; 2:498-502.
35. Feldman S., Bisno A.L., Lott L., Dodge R., Jackson R.E. Efficacy of benzathine penicillin G in group A streptococcal pharyngitis: reevaluation. J Pediatr 1987; 110:783-787
36. Kaplan E.L., Gastanaduy A.S., Huwe B.B. The role of the carrier in treatment failures after antibiotic therapy for group A streptococci in the upper respiratory tract. J Lab Clin Med 1981; 98:326-335
37. Brook I. Role of beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococci. Pediatr Infect Dis 1985; 4:491-495
38. Tanz R.R., Shulman S.T., Sroka P.A., Marubio S., Brook I., Yogev R. Lack of influence of beta-lactamase-producing flora on recovery of group A streptococci after treatment of acute pharyngitis. J Pediatr 1990; 117:859-863
39. Kim K.S., Kaplan E.L. Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis. J Pediatr 1985; 107:681-684
40. Smith T.D., Huskins W.C., Kim K.S., Kaplan E.L. Efficacy of beta-lactamase-resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for group A streptococcal pharyngitis. J Pediatr 1987; 110:777-782
41. Dajani A.S., Bisno A.L., Chung K.J., et al. Prevention of rheumatic fever: a statement for health professionals by the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Circulation 1988; 78:1082-1086
42. Pichichero M.E., Margolis P.A. A comparison of cephalosporins and penicillins in the treatment of Group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Dis J 1991; 10:275-281
43. Chaudhary S., Bilinsky A.S., Hennessy J.L., et al. Penicillin V and rifampin for the treatment of group A streptococcal pharyngitis: a randomized trial of 10 days penicillin vs 10 days penicillin with rifampin during the final 4 days of therapy. J Pediatr 1985; 106:481-486
44. Kaplan E.L., Johnson D.R. Eradication of group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure. J Pediatr 1988; 113:400-403
45. Tanz R.R., Shulman S.T., Barthel M.J., Willert C., Yogev R. Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci. J Pediatr 1985; 106:876-880
46. Gordis L. The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. Circulation 1985; 72:1155-1162
47. Masseil B.F., Chute C.G., Walker A.M., Kurland G.S. Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. N Engl J Med 1988; 318:280-286
48. Gordis L., Lilienfeld A., Rodriguez R. Studies in the epidemiology and preventability of rheumatic fever. I. Demographic factors and the incidence of acute attacks. J Chronic Dis 1969; 21:645-654
49. Gordis L. Changing risk of rheumatic fever. In: Shulman ST, ed. Pharyngitis: management in an era of declining rheumatic fever. New York: Praeger Scientific, 1984: 13-22.
50. Schwartz R.H., Hepner S.I., Ziai M. Incidence of acute rheumatic fever: a suburban community hospital experience during the 1970s. Clin Pediatr (Phila) 1983; 22:798-801.
51. Odio A. The incidence of acute rheumatic fever in a suburban area of Los Angeles: a ten-year study. West J Med 1986; 144:179-184
52. Land M.A., Bisno A.L. Acute rheumatic fever: a vanishing disease in suburbia. JAMA 1983; 249:895-898
53. Quinn R.W., Federspiel C.F. The incidence of rheumatic fever in metropolitan Nashville, 1963—1969. Am J Epidemiol 1974; 99:273-280
54. Ferguson G.W., Shultz J.M., Bisno A.L. Epidemiology of acute rheumatic fever in a multi-ethnic, multi-racial U.S. urban community. J Infect Dis (in press).
55. Brownell K.D., Bailen-Rose F. Acute rheumatic fever in children: incidence in a borough of New York City. JAMA 1973; 224:1593-1597
56. Griffiths S.P., Gersony W.M. Acute rheumatic fever in New York City (1969 to 1988): a comparative study of two decades. J Pediatr 1990; 116:882-887
57. Markowitz M. The decline of rheumatic fever: role of medical intervention. J Pediatr 1985; 106:545-550
58. Coburn A.F., Pauli R.H. Studies on the immune response of the rheumatic subject and its relationship to activity of the rheumatic process. IV. Characteristics of strains of hemolytic streptococcus, effective and noneffective in initiating rheumatic activity. J Clin Invest 1935; 14:755-762
59. Bisno A.L. The concept of rheumatogenic and nonrheumatogenic group A streptococci. In: Read SE, Zabriskie JB, eds. Streptococcal diseases and the immune response. New York: Academic Press, 1980: 789-803.
60. Bisno A.L., Pearce I.A., Wall H.P., Moody M.D., Stollerman G.H. Contrasting epidemiology of acute rheumatic fever and acute glomerulonephritis: nature of the antecedent streptococcal infection. N Engl J Med 1970; 283:561-565
61. Potter E.V., Svartman M., Mohammed I., Cox R., Poon-King T., Earle D.P. Tropical acute rheumatic fever and associated streptococcal infections compared with concurrent acute glomerulonephritis. J Pediatr 1978; 92:325-333
62. Bisno A.L., Berrios X., Quesney F., Monroe D.M. Jr., Dale J.B., Beachey E.H. Type-specific antibodies to structurally defined fragments of streptococcal M proteins in patients with acute rheumatic fever. Infect Immun 1982; 38:573-579
63. Bisno A.L., Pearce I.A., Stollerman G.H. Streptococcal infections that fail to cause recurrences of rheumatic fever. J Infect Dis 1977; 136:278-285
64. Kuttner A.G., Krumwiede E. Observations on the effect of streptococcal upper respiratory infections on rheumatic children: a three-year study. J Clin Invest 1941; 20:273-287
65. Berrios X., Quesney F., Morales A., Blasquez J., Lagomarsino E., Bisno A.L. Acute rheumatic fever and poststreptococcal glomerulonephritis in an open population: comparative studies of epidemiology and bacteriology. J Lab Clin Med 1986; 108:535-542
66. Majeed H.A., Khuffash F.A., Yousof A.M., et al. The rheumatogenic and nephritogenic strains of the group A streptococcus: the Kuwait experience. N Z Med J 1988; 101:398-401.
67. Lennon D., Martin D., Wong E., Taylor L.R. Longitudinal study of poststreptococcal disease in Auckland: rheumatic fever, glomerulonephritis, epidemiology and M typing 1981—86. N Z Med J 1988; 101: 396-8.
68. Potter E.V., Svartman M., Burt E.G., Finklea J.F., Poon-King T., Earle D.P. Relationship of acute rheumatic fever to acute glomerulonephritis in Trinidad. J Infect Dis 1972; 125:619-625
69. Kaplan E.L., Top F.H. Jr., Dudding B.A., Wannamaker L.W. Diagnosis of streptococcal pharyngitis: differentiation of active infection from the carrier state in the symptomatic child. J Infect Dis 1971; 123:490-501.
70. Schwartz B., Facklam R.R., Breiman R.F. Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990; 336:1167-1171
71. Stollerman G.H. The relative rheumatogenicity of strains of group A streptococci. Mod Concepts Cardiovasc Dis 1975; 44:35-40.
72. Veasy L.G., Wiedmeier S.E., Orsmond G.S., et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 1987; 316:421-427
73. Veasy L.G., Hill H.R. Clinical features of acute rheumatic fever recrudescence in the inter-mountain area of the United States. Presented at the XI Lancefield Symposium on Streptococci and Streptococcal Diseases, Siena, Italy, September 10–14, 1990.
74. Hosier D.M., Craenen J.M., Teske D.W., Wheller J.J. Resurgence of acute rheumatic fever. Am J Dis Child 1987; 141:730-733
75. Congeni B., Rizzo C., Congeni J., Sreenivasan V.V. Outbreak of acute rheumatic fever in northeast Ohio. J Pediatr 1987; 111:176-179
76. Wald E.R., Dashefsky B., Feidt C., Chiponis D., Byers C. Acute rheumatic fever in western Pennsylvania and the tristate area. Pediatrics 1987; 80:371-374
77. Westlake R.M., Graham T.P., Edwards K.M. An outbreak of acute rheumatic fever in Tennessee. Pediatr Infect Dis J 1990; 9:97-100.
78. Leggiadro R.J., Birnbaum S.E., Chase N.A., Myers L.K. A resurgence of acute rheumatic fever in a mid-South children#x0027;s hospital. South Med J 1990; 83:1418-1420
79. Jackson M.A., Sotiropoulos S.V., Christensen B., Diehl A.M., Kaplan E.L. Mucoid Group A streptococcal disease in Kansas City, MO. Pediatr Res 1988; 23:Suppl:372A
80. Bums D.L., Ginsburg C.M. Recrudescence of acute rheumatic fever in Dallas, Texas. Pediatr Res 1987; 21:Suppl:256A
81. Bisno A.L. The resurgence of acute rheumatic fever in the United States. Annu Rev Med 1990; 41:319-329
82. Acute rheumatic fever — Utah. MMWR 1987; 36:108-10, 115.
83. Kavey R.E., Kaplan E.L. Resurgence of acute rheumatic fever. Pediatrics 1989; 84:585-586
84. Thomas R.J., Conwill D.E., Morton D.E., Brooks T.J., Holmes C.K., Mahaffey W.B. Penicillin prophylaxis for streptococcal infections in United States Navy and Marine Corps recruit camps, 1951—1985. Rev Infect Dis 1988; 10:125-130
85. Heggie A.D. Prevention of Streptococcal pharyngitis and acute rheumatic fever in Navy and Marine Corps recruits. Navy Med 1988; 79(2):26-28
86. Wallace M.R., Garst P.D., Papadimos T.J., Oldfield E.C. III. The return of acute rheumatic fever in young adults. JAMA 1989; 262:2557-2561
87. Acute rheumatic fever among Army trainees — Fort Leonard Wood, Missouri, 1987—1988. MMWR 1988; 37:519-522
88. Kaplan E.L., Johnson D.R., Cleary P.P. Group A streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the mid-1980s. J Infect Dis 1989; 159:101-103
89. Marcon M.J., Hribar M.M., Hosier D.M., et al. Occurrence of mucoid M-18 Streptococcus pyogenes in a central Ohio pediatric population. J Clin Microbiol 1988; 26:1539-1542
90. Fillit H.M., McCarty M., Blake M. Induction of antibodies to hyaluronic acid by immunization of rabbits with encapsulated streptococci. J Exp Med 1986; 164:762-776
91. Fillit H.M., Blake M., MacDonald C., McCarty M. Immunogenicity of liposome-bound hyaluronate in mice: at least two different antigenic sites on hyaluronate are identified by mouse monoclonal antibodies. J Exp Med 1988; 168:971-982
92. James L., McFarland R.B. An epidemic of pharyngitis due to a nonhemolytic group A streptococcus at Lowry Air Force Base. N Engl J Med 1971; 284:750-752
93. Rammelkamp C.H., Denny F.W., Wannamaker L.W. Studies on the epidemiology of rheumatic fever in the armed services. In: Thomas L, ed. Rheumatic fever. Minneapolis: University of Minnesota Press, 1952: 72-89.
94. Khandke K.M., Fairwell T., Manjula B.N. Difference in the structural features of streptococcal M proteins from nephritogenic and rheumatogenic serotypes. J Exp Med 1987; 166:151-162
95. Bessen D., Jones K.F., Fischetti V.A. Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever. J Exp Med 1989; 169:269-283
96. Dale J.B., Beachey E.H. Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med 1985; 162:583-591
97. Dale. Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart. J Exp Med 1982; 156:1165-1176
98. Ayoub E.M., Barrett D.J., Maclaren N.K., Krischer J.P. Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest 1986; 77:2019-2026
99. Anastasiou-Nana M.I., Anderson J.L., Carlquist J.F., Nanas J.N. HLA-DR typing and lymphocyte subset evaluation in rheumatic heart disease: a search for immune response factors. Am Heart J 1986; 112:992-997
100. Khanna A.K., Buskirk D.R., Williams R.C. Jr., et al. Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. J Clin Invest 1989; 83:1710-1716
101. Regelmann W.E., Talbot R., Cairns L., et al. Distribution of cells bearing “rheumatic” antigens in peripheral blood of patients with rheumatic fever/rheumatic heart disease. J Rheumatol 1989; 16:931-935
102. Stevens D.L., Tanner M.H., Winship J., et al. Severe group A streptococcal infections associated with a toxic shock—like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321:1-7.
103. Cone L.A., Woodard D.R., Schlievert P.M., Tomory G.S. Clinical and bacteriologic observations of a toxic shock—like syndrome due to Streptococcus pyogenes. N Engl J Med 1987; 317:146-149
104. Banter T., Dascal A., Carroll K., Curley F.J. “Toxic strep syndrome”: a manifestation of group A streptococcal infection. Arch Intern Med 1988; 148:1421-1424
105. Connolly T.J., Pavelka D.J., Lanspa E.F., Connolly T.L. Toxic shock-like syndrome associated with necrotizing Streptococcus pyogenes infection. Henry Ford Hosp Med J 1989; 37:69-72.
106. Drabick J.J., Lennox J.L. Group A streptococcal infections and a toxic shock—like syndrome. N Engl J Med 1989; 321:1545.
107. Stollerman G.H. Changing group A streptococci: the reappearance of streptococcal “toxic shock”. Arch Intern Med 1988; 148:1268-70
108. Erratum, Arch Intern Med 1988; 148:2600
109. Begovac J., Marlon E., Lisie M., Beus I., Bozinovic D., Kuzmanovic N. Group A beta-hemolytic streptococcal toxic shock-like syndrome. Pediatr Infect Dis J 1990; 9:369-370
110. Hribalova V. Streptococcus pyogenes and the toxic shock syndrome. Ann Intern Med 1988; 108:772.
111. Hansman D., Jarvinen A. Group A streptococcal infections and a toxic shock—like syndrome. N Engl J Med 1989; 321:1546.
112. Shaunak S., Wendon J., Monteil M., Gordon A.M. Septic scarlet fever due to Streptococcus pyogenes cellulitis. Q J Med 1988; 69:921-925
113. Smyth E.G., Weinbren M.J. Severe group A streptococcal infection. Lancet 1988; 2:452.
114. Hoge C., Schwartz B., Porter B., et al. Population-based study of invasive group A streptococcal (GAS) infections. In: Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, October 21–24, 1990. Washington, D.C.: American Society for Microbiology, 1990.
115. Beachey E.H., Stollerman G.H. The common antigen(s) of streptococcal M protein vaccines causing hyperimmune reactions in man. Trans Assoc Am Physicians 1972; 85:212-221
116. Beachey. Toxic effects of streptococcal M protein on platelets and polymorphonuclear leukocytes in human blood. J Exp Med 1971; 134:351-365
117. Tomai M., Kotb M., Majumdar G., Beachey E.H. Superantigenicity of streptococcal M protein. J Exp Med 1990; 172:359-362
118. Greenblatt J., Boackle R.J., Schwab J.H. Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall. Infect Immun 1978; 19:296-303.
119. Fiedel B.A., Jackson R.W. Activation of the alternative complement pathway by a streptococcal lipoteichoic acid. Infect Immun 1978; 22:286-287
120. Quinn R.W. Comprehensive review of morbidity and mortality trends for rheumatic fever, streptococcal disease, and scarlet fever: the decline of rheumatic fever. Rev Infect Dis 1989; 11:928-953
121. Top F.H. Hemolytic streptococcal infections. In: Top FH, ed. Communicable and infectious diseases: diagnosis, prevention, treatment. 5th ed. St. Louis: C.V. Mosby, 1964: 319-55.
122. Stollerman G.H. Landmark perspective: the historical role of the Dick test. JAMA 1983; 250:3097-3099
123. Willoughby R., Greenberg R.N. The toxic shock syndrome and streptococcal pyrogenic exotoxins. Ann Intern Med 1983; 98:559.
124. Bohach G.A., Fast D.J., Nelson R.D., Schlievert P.M. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 1990; 17:251-272
125. Gaworzewska E.T., Hallas G. Group A streptococcal infections and a toxic shock—like syndrome. N Engl J Med 1989; 321:1546.
126. Baddour L.M., Bisno A.L. Recurrent cellulitis after saphenous venectomy for coronary bypass surgery. Ann Intern Med 1982; 97:493-496
127. Baddour. Non-group A beta-hemolytic streptococcal cellulitis: association with venous and lymphatic compromise. Am J Med 1985; 79:155-159
128. Barg N.L., Kish M.A., Kauffman C.A., Supena R.B. Group A streptococcal bacteremia in intravenous drug abusers. Am J Med 1985; 78:569-574
129. Lentnek A.L., Giger O., O#x0027;Rourke E. Group A beta-hemolytic streptococcal bacteremia and intravenous substance abuse: a growing clinical problem? Arch Intern Med 1990; 150:89-93.
130. Craven D.E., Rixinger A.I., Bisno A.L., Goularte T.A., McCabe W.R. Bacteremia caused by group G streptococci in parenteral drug abusers: epidemiological and clinical aspects. J Infect Dis 1986; 153:988-992
131. Bisno A.L., Craven D.E., McCabe W.R. M proteins of group G streptococci isolated from bacteremic human infections. Infect Immun 1987; 55:753-757
132. Group A beta-hemolytic streptococcal bacteremia — Colorado, 1989. MMWR 1990; 39:3-6, 11.
133. Thomas J.C., Carr S.J., Fujioka K., Waterman S.H. Community-acquired group A streptococcal deaths in Los Angeles County. J Infect Dis 1989; 160:1086-1087
134. Nursing home outbreaks of invasive group A streptococcal infections —Illinois, Kansas, North Carolina, and Texas. MMWR 1990; 39:577-579
135. Bibler M.R., Rouan G.W. Cryptogenic group A streptococcal bacteremia: experience at an urban general hospital and review of the literature. Rev Infect Dis 1986; 8:941-951
136. Ruben F.L., Norden C.W., Heisler B., Korica Y. An outbreak of Streptococcus pyogenes infections in a nursing home. Ann Intern Med 1984; 101:494-496
137. Francis J., Warren R.E. Streptococcus pyogenes bacteraemia in Cambridge — a review of 67 episodes. Q J Med 1988; 68:603-613
138. Reid R.I., Briggs R.S., Seal D.V., Pearson A.D. Virulent Streptococcus pyogenes: outbreak and spread within a geriatric unit. J Infect 1983; 6:219-225
139. Dan M., Maximova S., Siegman-Igra Y., Gutman R., Rotmensch H.H. Varied presentations of sporadic group A streptococcal bacteremia: clinical experience and attempt at classification. Rev Infect Dis 1990; 12:537-542
140. Ispahani P., Donald F.E., Aveline A.J. Streptococcus pyogenes bacteraemia: an old enemy subdued, but not defeated. J Infect 1988; 16:37-46.
141. Belani K., Schlievert P.M., Kaplan E.L., Fenieri P. Association of exotoxin-producing Group A streptococci and severe disease in children. Pediatr Infect Dis J 1991; 10:351-354
142. Acharya U., Lamont C.A.R., Cooper K. Group A beta-haemolytic streptococcus causing disseminated intravascular coagulation and maternal death. Lancet 1988; 1:595.
143. Kavi J., Wise R. Group A beta-haemolytic Streptococcus causing disseminated intravascular coagulation and maternal death. Lancet 1988; 1:993-994
144. Swingler G.R., Bigrigg M.A., Hewitt B.G., McNulty C.A.M. Disseminated intravascular coagulation associated with group A streptococcal infection in pregnancy. Lancet 1988; 1:1456-1457
145. Martin P.R., Hiby E.A. Streptococcal serogroup A epidemic in Norway 1987—1988. Scand J Infect Dis 1990; 22:421-429
146. Holm S.E., Bergholm A.M. Pathogenic aspects of an outbreak of serious streptococcal infections in Sweden 1988–1989. Presented at the XI Lancefield Symposium on Streptococci and Streptococcal Diseases, Siena, Italy, September 10–14, 1990
147. Gaworzewska E., Colman G. Changes in the pattern of infection caused by Streptococcus pyogenes. Epidemiol Infect 1988; 100:257-269
148. Bisno A.L. The coexistence of acute rheumatic fever and acute glomerulonephritis. Arthritis Rheum 1989; 32:230-232
149. Fischetti V.A., Hodges W.M., Hruby D.E. Protection against streptococcal pharyngeal colonization with a vaccinia: M protein recombinant. Science 1989; 244:1487-1490
150. Beachey E.H., Stollerman G.H., Johnson R.H., Ofek I., Bisno A.L. Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein. J Exp Med 1979; 150:862-877
151. Poirier T.P., Kehoe M.A., Beachey E.H. Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein. J Exp Med 1988; 168:25-32.